Credit: Pixabay/CC0 Public Domain

Researchers from NeuRA and UNSW Sydney have launched a new app aimed at boosting the well-being and resilience of adults. This innovative mobile application, called ReNeuWell, shifts the focus from managing distress to actively promoting mental flourishing, offering a neuroscience-backed, personalized approach to mental health.

Designed by Associate Professor Justine Gatt, director of the Center for Well-being, Resilience and Recovery at NeuRA and UNSW's School of Psychology, ReNeuWell is underpinned by the COMPAS-W Well-being Scale. This validated tool assesses both subjective (hedonic–composure, positivity, life satisfaction) and psychological (eudaimonic—self-worth, mastery, achievements) well-being, providing users with a comprehensive profile.

"The app is designed for anyone looking for ways to understand and boost their own level of mental well-being, " states Associate Professor Gatt, emphasizing its role in guiding individuals towards optimal mental health.

ReNeuWell offers a unique personalized program of activities over four-week periods, drawing on psychological concepts such as mindfulness, meditation, self-compassion, and goal-setting.

These activities are tailored to improve specific aspects of a user's well-being, grounded in the COMPAS-W scale's proven link to brain function, genetics, cognitive performance, and even physical health indicators.

A 12-week clinical trial is currently underway, with NeuRA actively recruiting at least 500 adult participants from the general public. Eligible individuals will receive free access to the app, committing to just 10 minutes of daily use and three short surveys. This trial aims to further validate the app's effectiveness and gather user feedback for refinement.

Developed by Miroma Project Factory, ReNeuWell exemplifies a successful collaboration between research and industry to address real-world mental health needs.

The ReNeuWell app is now available for download on the Apple App Store in Australia for a one-time fee of AUD$24.99 for those who do not wish to participate in the trial.